Advertisement
U.S. patients whose health insurance plans have high deductibles undergo fewer diagnostic imaging tests

Diagnostic Imaging Down With High Deductible Health Plans

0
Patients may not be equipped to discern which tests are medically necessary
A physician's body language may reveal racial bias against seriously ill black patients

Nonverbal Cues May Reveal a Physician’s Racial Bias

0
Doctors need to be aware of any unintentional biases they may be communicating
A growing number of teens

Incidence of Nephrolithiasis Rising in Teens, Blacks

0
Researchers also report growing number of cases among women and children
A new online tool may help predict whether patients with chronic kidney disease will develop kidney failure in the next two to five years. The report was published in the Jan. 12 issue of the Journal of the American Medical Association.

Online Tool Helps Predict Odds of Kidney Failure in CKD Patients

0
New risk calculator estimates who will need dialysis in two to five years
Even a slight decline in kidney function can potentially lead to heart damage

Even Small Decline in Kidney Function Tied to CVD Risk

0
Associated with an increase in the mass of the left ventricle

ASCO Genitourinary Cancers Symposium, Jan. 7-9

0
The ASCO 2016 Genitourinary Cancers Symposium The annual Genitourinary Cancers Symposium of the American Society of Clinical Oncology was held from Jan. 7...
Patients on hemodialysis often have drug orders that are not adherent to renal dosing recommendations

Dosing Errors Occur Frequently in Patients With Renal Failure

0
Primary factor for nonadherence to renal dosing is characteristics of medical institution
Use of proton pump inhibitors may be linked to long-term kidney damage

Proton Pump Inhibitors Linked to Chronic Kidney Disease

0
While study can't prove cause-and-effect, increasing damage seen as dose rises
Since peaking in 1991

U.S. Cancer Mortality Rates Down 23 Percent Since 1991

0
That translates to an additional 1.7 million survivors
For patients with advanced renal cell carcinoma

ASCO: Cabozantinib Improves Progression-Free Survival in RCC

0
Improvements seen across patient subgroups defined by risk category, tumor burden, prior therapy